OMNIgene GUT Dx
Device To Preserve And Stabilize Relative Abundances Of Microbial Nucleic Acids In Clinical Samples
DNA Genotek Inc.
The following data is part of a De Novo classification by Dna Genotek Inc. with the FDA for Omnigene Gut Dx.
Pre-market Notification Details
DeNovo ID | DEN200040 |
Device Name: | OMNIgene GUT Dx |
Classification | Device To Preserve And Stabilize Relative Abundances Of Microbial Nucleic Acids In Clinical Samples |
Applicant | DNA Genotek Inc. 3000 - 500 Palladium Drive Ottawa, CA K2v 1c2 |
Contact | Austin Udocor |
Product Code | QPO |
CFR Regulation Number | 866.2952 [🔎] |
Decision | Granted (DENG) |
510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(De Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
Review Advisory Board | Microbiology |
Classification Advisory | Microbiology |
Type | Direct |
Date Received | 2020-06-15 |
Decision Date | 2021-11-03 |
Reclassification Order: | Reclassification Order |
NIH GUDID Devices
Device Identifier | submissionNumber | Supplement |
00627595000774 |
DEN200040 |
000 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.